Drug Type Small molecule drug |
Synonyms M-402 free acid, Necuparanib, Necuparanib sodium (USAN) + [6] |
Target |
Mechanism HSPGs modulators(Heparan sulfate proteoglycan protein modulators), Angiogenesis inhibitors |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Ductal Adenocarcinoma | Phase 2 | - | 15 Apr 2013 | |
Secondary malignant neoplasm of pancreas | Phase 2 | US | 01 May 2012 | |
Secondary malignant neoplasm of pancreas | Phase 2 | CA | 01 May 2012 |
Phase 2 | 120 | oauvbzhimq(ubrqjrrada) = abjqzoshjo cbnbjairjx (svlzipprxv ) View more | Negative | 21 Mar 2017 | |||
Placebo | oauvbzhimq(ubrqjrrada) = lbecoptvbc cbnbjairjx (svlzipprxv ) View more |